Pricing Log in Create free account
Sunday 8 November 2026 Export GILD’s income statement to Excel — free account

Gilead Sciences, Inc.

GILD

Healthcare Drug Manufacturers General

Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024.

Revenue
+6.83%
EPS
−20.5%
Free cash flow
+21.1%
Total debt
+5.17%

Quarter to September 2026, against a year earlier

166.89 0.68 −0.41%
Market cap
$207.8B
P/E
n/m
Fwd P/E
n/m
Dividend yield
1.95%
F-score
8/9
ROIC
−4.51%
Net debt / EBITDA
1.4×
Dividend safety
77/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Gilead Sciences, Inc. (GILD) Book value per share

Alert me on Book value per share

Gilead Sciences, Inc.'s book value per share at the end of fiscal 2025 was 18.2×, up 17.8% from 15.4× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 10.4×. Over the past ten years it has ranged from 13.1× (fiscal 2015) to 18.2× (fiscal 2023); the current reading is higher than 91% of that period. Gilead Sciences, Inc. ranks 13th of 21 Drug Manufacturers General companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 18.2× 17.80%
FY2024 15.4× (15.33%)
FY2023 18.2× 7.86%
FY2022 16.9× 0.77%
FY2021 16.8× 15.70%
FY2020 14.5× (18.72%)
FY2019 17.8× 7.50%
FY2018 16.6× 5.77%
FY2017 15.7× 8.47%
FY2016 14.5× 10.77%

Quarterly newest first

Period Book value per share Change
Sep 2026 10.4× 10.40%
Jun 2026 9.4× (49.92%)
Mar 2026 18.9× 3.76%
Dec 2025 18.2× 5.33%
43 more quarters

Against its own ten years

Low 13.1× High 18.2×
Ten-year median 16.6×
Current reading's percentile 91

Book value per share against peers

Company Book value per share
SNY Sanofi compare 35.1×
AZN AstraZeneca PLC compare 33.4×
AMGN Amgen Inc. compare 26.5×
NVS Novartis AG compare 19.8×
MRK Merck & Co., Inc. compare 18.2×
PFE Pfizer Inc. compare 15.7×
BMY Bristol Myers Squibb Company compare 11.5×
GILD Gilead Sciences, Inc. 10.4×
NVO Novo Nordisk A/S compare 7.6×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on GILD